Medicare Enrolled
Dr. Antwan Ahad, MD
Neurology · Secaucus, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ahad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ahad?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ahad
Dr. Antwan Ahad is a neurology specialist in Secaucus, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Ahad performed 1,294 Medicare services across 824 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ahad received a total of $39,225 from 88 pharmaceutical and/or device companies across 1766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ahad is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 28% volume in NJ
$39,225 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,294
Medicare services
Top 28% in NJ for neurology
824
Unique beneficiaries
$149
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~68 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
693 | $102 | $301 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
143 | $414 | $850 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
94 | $89 | $850 |
| New patient office visit, complex (60-74 min) | 85 | $183 | $573 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 74 | $217 | $700 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
61 | $150 | $404 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
34 | $186 | $373 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
33 | $12 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $73 | $206 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
26 | $0 | $20 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
13 | $196 | $550 |
| Continuous EEG brain wave monitoring A test that records electrical activity in the brain over an extended period. It is used to monitor brain function continuously. |
11 | $199 | $500 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$39,225
Total received (2018-2024)
Avg $5,604/year across 7 years
Top 10% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
1,766
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$38,849 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$377 (1.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,825
2023
$7,204
2022
$7,783
2021
$5,972
2020
$3,227
2019
$4,527
2018
$2,687
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
EMD Serono, Inc.
$1,087
ABBVIE INC.
$907
Lundbeck LLC
$476
PFIZER INC.
$472
Biogen, Inc.
$395
Amneal Pharmaceuticals LLC
$357
Novocure Inc.
$318
Lilly USA, LLC
$296
Teva Pharmaceuticals USA, Inc.
$262
Sumitomo Pharma America, Inc.
$248
UCB, Inc.
$246
Novartis Pharmaceuticals Corporation
$228
Otsuka America Pharmaceutical, Inc.
$209
Eisai Inc.
$201
AstraZeneca Pharmaceuticals LP
$184
Azurity Pharmaceuticals, Inc.
$180
Axsome Therapeutics, Inc.
$158
Celgene Corporation
$144
Vanda Pharmaceuticals Inc.
$138
SCILEX PHARMACEUTICALS INC.
$136
Neurocrine Biosciences, Inc.
$133
Medtronic, Inc.
$128
E.R. Squibb & Sons, L.L.C.
$125
Avadel CNS Pharmaceuticals, LLC
$125
SK Life Science, Inc.
$100
Alexion Pharmaceuticals, Inc.
$68
Amgen Inc.
$68
CSL Behring
$55
ARGENX US, INC.
$52
Neurelis, Inc.
$47
Aucta Pharmaceuticals, Inc.
$39
Grifols USA, LLC
$35
Genentech USA, Inc.
$35
ANI Pharmaceuticals, Inc.
$33
Octapharma USA, Inc.
$31
ACADIA Pharmaceuticals Inc
$31
GE HEALTHCARE
$17
Kyowa Kirin, Inc.
$17
JAZZ PHARMACEUTICALS INC.
$16
BANNER LIFE SCIENCES, LLC
$15
Acorda Therapeutics, Inc
$15
Top 3 companies account for 31.6% of 2024 payments
All-time payments by company (2018-2024) ›
EMD Serono, Inc.
$3,957
Biogen, Inc.
$2,737
AbbVie Inc.
$1,879
ABBVIE INC.
$1,683
SK Life Science, Inc.
$1,546
Lundbeck LLC
$1,500
Abbott Laboratories
$1,459
Novartis Pharmaceuticals Corporation
$1,371
Lilly USA, LLC
$1,326
Sunovion Pharmaceuticals Inc.
$1,054
Amneal Pharmaceuticals LLC
$1,022
Celgene Corporation
$939
Alexion Pharmaceuticals, Inc.
$892
Teva Pharmaceuticals USA, Inc.
$796
PFIZER INC.
$762
Neurocrine Biosciences, Inc.
$761
UCB, Inc.
$747
Sumitomo Pharma America, Inc.
$661
Eisai Inc.
$600
Supernus Pharmaceuticals, Inc.
$552
Genentech USA, Inc.
$552
Neurelis, Inc.
$550
US WorldMeds, LLC
$547
ACADIA Pharmaceuticals Inc
$504
E.R. Squibb & Sons, L.L.C.
$485
Monteris Medical Corporation
$472
Medtronic, Inc.
$461
GENZYME CORPORATION
$419
Amgen Inc.
$404
Allergan, Inc.
$390
Janssen Pharmaceuticals, Inc
$389
ARGENX US, INC.
$381
Kyowa Kirin, Inc.
$372
Biohaven Pharmaceutical Holding Company Ltd.
$358
CSL Behring
$318
Novocure Inc.
$318
EISAI INC.
$317
IMPEL PHARMACEUTICALS INC.
$317
AstraZeneca Pharmaceuticals LP
$303
Acorda Therapeutics, Inc
$285
Otsuka America Pharmaceutical, Inc.
$258
SCILEX PHARMACEUTICALS INC.
$233
Scilex Pharmaceuticals Inc.
$228
Almatica Pharma LLC
$227
ANI Pharmaceuticals, Inc.
$203
JAZZ PHARMACEUTICALS INC.
$203
Grifols USA, LLC
$200
Currax Pharmaceuticals LLC
$195
Azurity Pharmaceuticals, Inc.
$194
Biohaven Pharmaceuticals, Inc.
$184
Medtronic USA, Inc.
$175
Axsome Therapeutics, Inc.
$158
Avanir Pharmaceuticals, Inc.
$149
Allergan Inc.
$143
CATALYST PHARMACEUTICALS, INC.
$140
Vanda Pharmaceuticals Inc.
$138
Avadel CNS Pharmaceuticals, LLC
$125
TG THERAPEUTICS, INC.
$125
ARBOR PHARMACEUTICALS, INC.
$124
Philips Electronics North America Corporation
$120
Edwards Lifesciences Corporation
$98
Horizon Therapeutics plc
$84
MDD US Operations, LLC
$82
Adamas Pharmaceuticals, Inc.
$75
Octapharma USA, Inc.
$75
UPSHER-SMITH LABORATORIES LLC
$73
Mallinckrodt Hospital Products Inc.
$71
LivaNova USA, Inc.
$69
AQUESTIVE THERAPEUTICS, INC.
$65
SANOFI-AVENTIS U.S. LLC
$65
GE HealthCare
$59
GE HEALTHCARE
$57
BANNER LIFE SCIENCES, LLC
$44
Banner Life Sciences, LLC
$43
Avion Pharmaceuticals
$40
Zyla Life Sciences
$40
Aucta Pharmaceuticals, Inc.
$39
Endo Pharmaceuticals Inc.
$35
GRT US Holding, Inc.
$34
Exeltis, USA Inc.
$34
Bausch Health US, LLC
$29
Boston Scientific Corporation
$24
Ironwood Pharmaceuticals, Inc
$19
Upsher-Smith Laboratories LLC
$15
Takeda Pharmaceuticals U.S.A., Inc.
$14
Horizon Pharma plc
$14
Zyla Life Sciences, Inc.
$13
Amarin Pharma Inc.
$12
Top 3 companies account for 21.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · ACTIVA · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · Auvelity · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Briviact · COMIRNATY · COPAXONE · CREXONT · Cenobamate · DUEXIS · Dhivy · ELYXYB - CELECOXIB · EMGALITY · EPIDIOLEX · Edwards SAPIEN 3 Transcatheter Heart Valve · Enspryng · FIRDAPSE · Fycompa · GILENYA · GOCOVRI · GRALISE · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LINZESS · LUMRYZ · LYVISPAH · Leqembi · Linzess · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · Motpoly XR · NAMZARIC · NAPRELAN · NASCOBAL · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Neuroblate · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · Ongentys · Optune · PANZYGA · PAXLOVID · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · Proclaim Family of SCS IPGs · QALSODY · QULIPTA · Qutenza · RAYOS · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYMPAZAN · Soliris · Sunosi · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRINTELLIX · TROKENDI XR · TYSABRI · Trudhesa · Tysabri · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VERCISE · VISUALASE · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vascepa · Vimpat · WAINUA · WELLBUTRIN · XADAGO · XCOPRI · Xadago · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for neurology in NJ.
Geographic Context
Neurologists within 10 mi
1,257
Per 100K population
176.9
County median income
$90,032
Nearest hospital
HUDSON REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ahad is a clinical cardiology specialist, with above-average Medicare volume (top 28% in NJ), with low-engagement industry engagement in the top 10% of NJ peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ahad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ahad performed 693 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ahad receive payments from pharmaceutical companies?
Yes. Dr. Ahad received a total of $39,225 from 88 companies across 1,766 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ahad's costs compare to other neurologists in Secaucus?
Dr. Ahad's average Medicare payment per service is $149. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ahad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Secaucus
Browse neurologists in Secaucus ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
EMD Serono, Inc. Payments to Doctors
See all physicians who received payments from EMD Serono, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology